000			03111nam a2200241Ia 4500
008			230420s2017 xx 000 0 und d
040			_cManila Tytana Colleges
100			_aHollander, Francis M. _93268
245		0	_aBody weight and body mass index in patients with end-stage cystic fibrosis stabilize after the start of enteral tube feeding / _cFrancis M. Hollander, Nicole M. de Roos, Gerdien Belle van Meerkerk, Ferdinand Teding van Berkhout, Harry G. M. Heijerman, Ed A. van de Graaf
260			_cNovember 2017
336			_atext
337			_aunmediated
338			_avolume
440			_n117 : 11, pages 1808-1815 _aJournal of the Academy of Nutrition and Dietetics _93269
520			_aBackground: Enteral tube feeding (ETF) is widely used in patients with cystic fibrosis (CF) and end-stage lung disease, but previous studies have been limited to investigating whether ETF improves outcomes in patients with moderately or mildly impaired pulmonary function. Objective: This study investigated body weight, body mass index (BMI; calculated as kg/m2), pulmonary function, and the presence of CF-related diabetes before and after the start of ETF. Design: This was a retrospective observational study. Participants/setting: Data from 26 adult patients in an outpatient setting who had end-stage CF (19 women) and had been using ETF for at least 6 months between 2000 and 2014 were analyzed. Main outcome measures: Body weight, BMI, pulmonary function (forced expiratory volume in 1 second as percent of predicted) and incidence of CF-related diabetes from 6 months before to 6 months after starting ETF. Statistical analyses performed: Time effects were tested with one-way analysis of variance for data that were normally distributed and the Friedman test for non-parametric data. Correlations were tested with Pearson's r or Spearman's ρ, depending on the distribution of the data. Results: Mean body weight increased by 3.5 kg (95% CI 2.2 to 4.8 kg) after patients started ETF. In women, mean BMI decreased by 0.7 in the 6 months before the start of ETF (P<0.05) and increased by 1.4 in the 6 months thereafter (P<0.05). In men, BMI changes were similar (-0.8 and +1.1), but not statistically significant. Forced expiratory volume in 1 second as percent of predicted significantly decreased in time from a median of 28% to 26% at the start of ETF to 25% after 6 months (P=0.0013), with similar trends in women and men. There was no correlation between changes in weight and lung function. CF-related diabetes was already present in 12 patients and developed in 1 more patient after the start of ETF. Conclusions: ETF improved body weight and BMI but not pulmonary function in 26 patients with end-stage CF. Clinical outcomes were similar in women and men, but the sample size of men was too small to determine statistical significance.
521			_aNutrition.
650			_aBody mass index.
650			_aCystic fibrosis-related diabetes. _93270
650			_aEnd-stage lung disease. _93271
650			_aEnteral tube feeding. _93272
650			_aPulmonary function. _93273
942			_cA
999			_c84229 _d84229